Real time dynamic imaging and current targeted therapies in the war on cancer: a new paradigm
10.7150/thno.5658 · doi-reference
Nitric oxide: biphasic dose responses
10.1080/20014091111776 · doi-reference
The multi-faceted behavior of nitric oxide in vascular “inflammation”: catchy terminology or true phenomenon?
10.1016/j.cardiores.2004.04.028 · doi-reference
Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent
10.1124/dmd.112.046755 · doi-reference
Dinitroazetidines are a novel class of anticancer agents and hypoxia-activated radiation sensitizers developed from highly energetic materials
10.1158/0008-5472.can-11-2303 · doi-reference
Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study
10.1016/s1470-2045(07)70001-3 · doi-reference
How cancer metabolism is tuned for proliferation and vulnerable to disruption
10.1038/nature11706 · doi-reference
Nitric oxide synthase inhibition enhances the antitumor effect of radiation in the treatment of squamous carcinoma xenografts
10.1371/journal.pone.0020147 · doi-reference
The role of nitric oxide in cancer
10.1038/sj.cr.7290133 · doi-reference
Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non–small-cell lung cancer
10.1200/jco.2005.04.0436 · doi-reference
Irradiation promotes Akt-targeting therapeutic gene delivery to the tumor vasculature
10.1016/j.ijrobp.2006.11.031 · doi-reference
Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview
10.1161/hh0102.102330 · doi-reference
Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1
10.1016/j.niox.2008.08.001 · doi-reference
Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells
10.4049/jimmunol.167.1.75 · doi-reference
MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation
10.1016/j.semcancer.2008.01.005 · doi-reference
Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation
10.4049/jimmunol.182.1.259 · doi-reference
Epigenetic control of the foxp3 locus in regulatory T cells
10.1371/journal.pbio.0050038 · doi-reference
Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate
10.1016/j.tox.2004.11.035 · doi-reference
p21ras as a common signaling target of reactive free radicals and cellular redox stress
10.1074/jbc.270.36.21195 · doi-reference
Nitrosative stress-induced apoptosis through inhibition of NF-κB
10.1074/jbc.m201638200 · doi-reference
Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway
10.4049/jimmunol.160.12.5729 · doi-reference
